Health: Cholesterol's One-Two Punch
Millions of Americans already take a drug to lower their LDL, or bad cholesterol, but if things go Pfizer's way, they may end up adding a pill that raises HDL, the good cholesterol that helps keep arteries clean. A study in the current New England Journal of Medicine reports that the drug torcetrapib boosted HDL levels 46%. When it was combined with the LDL-lowering drug Lipitor, the results were even more dramatic: HDL levels rose 61%, and LDL fell even more than it did with Lipitor alone. But will raising HDL levels mean lower rates of heart disease and fewer deaths? That's what Pfizer hopes to show. If it does, both the drug company and patients could be big winners.
--D.B.
Most Popular »
- How Cash Keeps Poor People Poor
- E.T. Turns 30: 10 Things You Didn't Know About Our Favorite Extraterrestrial
- No Spontanaeity Allowed: How to Visit North Korea as a Tourist in Four (Restrictive) Steps
- A New First Amendment Right: Videotaping The Police
- 15-Year-Old Creates Test for Pancreatic Cancer
- Fourth Flesh-Eating-Bacteria Case Confirmed in Georgia, Possible Fifth
- Nevada Ghosts: Rare Photos From an A-Bomb Test
- 10 Dangerous Products You Might Have in Your Home
- Euro Crisis: Why A Greek Exit Could Be Much Worse Than Expected
- Star Wars Turns 35: How TIME Covered the Film Phenomenon
- Researchers Probe the Potential Health Benefits of Palm Oil
- A Visit with Turkey's Controversial Religious Movement
- Feeding the Planet Without Destroying It
- Bubble on the Potomac
- Falcon's Liftoff: How a Private Firm Could Change Space Exploration
- The Fatal Flight of the Superjet 100: Why Did It Slam Into a Mountain?
- Learning That Works
- The Man Who Remade Motherhood
- Bibi's Choice
- Seoul: 10 Things to Do




